Acadia Pharmaceuticals Ownership & Insider Activity

Acadia Pharmaceuticals Inc

ACADNASDAQ

$19.73

-0.58-2.86%

Ult. Agg.: Oct 23, 5:29 PM

Utili: I risultati di Q3 2026 tra 11 giorni da adesso in mer nov 4th, dopo la chiusura del mercato

Acadia Pharmaceuticals Ownership & Insider Activity - Benzinga

Acadia Pharmaceuticals (ACAD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Aug 5, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$23.50	$228K
Jul 29, 2026	HZ Elizabeth Thompson	EVP, HEAD RESEARCH & DEV	SELL-OPTIONS	15.714K	$26.13	$433K
Jun 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	11.421K	$26.08	$298K
May 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	5.401K	$21.18	$114K
May 1, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL-OPTIONS	1.264K	$21.79	$29K
May 1, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	3.309K	$21.79	$76K

Date	Member	Party	Chamber	Action	Amount
Jun 16, 2022	Chris Jacobs	R	House	Sale	$1,001 - $15,000